Abstract
Rhinitis symptoms of rhinorrhea, congestion, sneezing, nasal/ocular pruritis, and postnasal drainage can significantly affect the quality of life for older adults. As the US population ages, it will be increasingly important for health-care providers to effectively diagnose and manage rhinitis. Rhinitis is categorized broadly into allergic rhinitis and non-allergic rhinitis. Environmental changes and avoidance measures are a primary means of intervention. In addition, there are several topical therapies (nasal sprays) that can be effective for symptom control.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Bhattacharyya N. Incremental healthcare utilization and expenditures for allergic rhinitis in the United States. Laryngoscope. 2011;121:1830–3.
Colas C, Galera H, Anibarro B, Soler R, Navarro A, Jauregui I, et al. Disease severity impairs sleep quality in allergic rhinitis (The SOMNIAAR study). Clin Exp Allergy. 2012;42:1080–7.
Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc. 2007;28:3–9.
Sanico A, Togias A. Noninfectious, nonallergic rhinitis (NINAR): considerations on possible mechanisms. Am J Rhinol. 1998;12:65–72.
Hanneuse Y, Delespesse G, Hudson D, De Halleux F, Jacques JM. Influence of Aging on IgE-Mediated Reactions in Allergic Patients. Clin Allergy. 1978;8:165–74.
Dykewicz MS, Fineman S, Skoner DP, Nicklas R, Lee R, Blessing-Moore J, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol. 1998;81:478–518.
Settipane RA. Other causes of rhinitis: mixed rhinitis, rhinitis medicamentosa, hormonal rhinitis, rhinitis of the elderly, and gustatory rhinitis. Immunol Allergy Clin North Am. 2011;31:457–67.
• Warm K, Backman H, Lindberg A, Lundback B, Ronmark E. Low incidence and high remission of allergic sensitization among adults. J Allergy Clin Immunol. 2012;129:136–42. This paper provides evidence that aging results in remission of allergic sensitivity. This is in contrast to the theories that differences in allergic sensitization in older versus younger patients are due to cohort effects.
Jessen M, Janzon L. Prevalence of non-allergic nasal complaints in an urban and a rural population in Sweden. Allergy. 1989;44:582–7.
Olsson P, Berglind N, Bellander T, Stjarne P. Prevalence of self-reported allergic and non-allergic rhinitis symptoms in Stockholm: relation to age, gender, olfactory sense and smoking. Acta Otolaryngol. 2003;123:75–80.
Settipane GA, Klein DE. Non allergic rhinitis: demography of eosinophils in nasal smear, blood total eosinophil counts and IgE levels. N Engl Reg Allergy Proc. 1985;6:363–6.
Crawford WW, Gowda VC, Klaustermeyer WB. Age effects on objective measures of atopy in adult asthma and rhinitis. Allergy Asthma Proc. 2004;25:175–9.
Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol. 2007;19:23–34.
Simola M, Holopainene E, Malmberg H. Changes in skin and nasal sensitivity to allergens and the course of rhinitis; a long-term follow-up study. Ann Allergy Asthma Immunol. 1999;82:152–6.
Long, A, McFadden, C, DeVine, D, Chew, P, Kupelnick, B, and Lau, J. Management of Allergic and Nonallergic Rhinitis. Rockville (MD): Agency for Healthcare Research and Quality (US). [54]. 2002. Evidence Reports/Technology Assessments.
Di Lorenzo G, Pacor ML, Amodio E, Leto-Barone MS, La Piana S, D'Alcamo A, et al. Differences and similarities between allergic and nonallergic rhinitis in a large sample of adult patients with rhinitis symptoms. Int Arch Allergy Immunol. 2011;155:263–70.
Moore EJ, Kern EB. Atrophic rhinitis: a review of 242 cases. Am J Rhinol. 2001;15:355–61.
Moneret-Vautrin DA, Hsieh V, Wayoff M, Guyot JL, Mouton C, Maria Y. Nonallergic rhinitis with eosinophilia syndrome a precursor of the triad: nasal polyposis, intrinsic asthma, and intolerance to aspirin. Ann Allergy. 1990;64:513–8.
Kramer MF, de la Chaux R, Fintelmann R, Rasp G. NARES: a risk factor for obstructive sleep apnea? Am J Otolaryngol. 2004;25:173–7.
Kaliner MA. Nonallergic rhinopathy (formerly known as vasomotor rhinitis). Immunol Allergy Clin North Am. 2011;31:441–55.
Broms P, Malm L. Oral vasoconstrictors in perennial non-allergic rhinitis. Allergy. 1982;37:67–74.
Kaliner MA. Azelastine and olopatadine in the treatment of allergic rhinitis. Ann Allergy Asthma Immunol. 2009;103:373–80.
Kaliner MA, Storms W, Tilles S, Spector S, Tan R, LaForce C, et al. Comparison of olopatadine 0.6 % nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis. Allergy Asthma Proc. 2009;30:255–62.
Ratner PH, Hampel F, van Bavel J, Amar NJ, Daftary P, Wheeler W, et al. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2008;100:74–81.
Hampel F, Ratner P, Haeusler JM. Safety and tolerability of levocetirizine dihydrochloride in infants and children with allergic rhinitis or chronic urticaria. Allergy Asthma Proc. 2010;31:290–5.
LaForce CF, Carr W, Tilles SA, Chipps BE, Storms W, Meltzer EO, et al. Evaluation of olopatadine hydrochloride nasal spray, 0.6 %, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis. Allergy Asthma Proc. 2010;31:132–40.
•• Feazel LM, Robertson CE, Ramakrishnan VR, Frank DN. Microbiome complexity and Staphylococcus aureus in chronic rhinosinusitis. Laryngoscope. 2012;122:467–72. This paper describes a novel concept of colonized microbes contributing to the inflammatory status in the nasal cavity. Future studies will be needed to address whether modifying the nasal microbiome can impact symptoms of rhinitis.
Hanski I, von Hertzen L, Fyhrquist N, Koskinen K, Torppa K, Laatikainen T, et al. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc Natl Acad Sci U S A. 2012;109:8334–9.
Broide DH. Allergic rhinitis: Pathophysiology. Allergy Asthma Proc. 2010;31:370–4.
•• Rondon C, Campo P, Galindo L, Blanca-Lopez N, Cassinello MS, Rodriguez-Bada JL, et al. Prevalence and clinical relevance of local allergic rhinitis. Allergy. 2012;67:1282–8. This paper highlights a growing body of evidence suggesting rhinitis symptoms can be due to a localized allergic sensitivity. Recognition of the localized allergic sensitivity or entopy will likely lead to new diagnostic techniques and new therapeutic options.
Acknowledgments
Dr. Mathur has received research grant support from the National Institutes of Health.
Disclosure
Dr. Nyenhuis has had travel and accommodations expenses covered and reimbursed by the American Thoracic Society.
Dr. Mathur has served as a consultant for Teva Pharmaceuticals. Dr. Mathur has also served as chair of the AAAAI Asthma and Allergic Diseases in the Elderly Committee and as secretary/treasurer of the Wisconsin Allergy Society.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nyenhuis, S.M., Mathur, S.K. Rhinitis in Older Adults. Curr Allergy Asthma Rep 13, 171–177 (2013). https://doi.org/10.1007/s11882-013-0342-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11882-013-0342-3